Production (Stage)
Cannabis Strategic Ventures
NUGS
$0.00
$0.000.00%
OTC PK
| 03/31/2021 | 12/31/2020 | 06/30/2020 | |||
|---|---|---|---|---|---|
| Revenue | 440.37% | 109.97% | 1,992.12% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 440.37% | 109.97% | 1,992.12% | ||
| Cost of Revenue | 553.75% | 126.55% | 1,244.90% | ||
| Gross Profit | -1,211.55% | 75.27% | 3,975.76% | ||
| SG&A Expenses | 31.36% | 23.16% | 9.90% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 132.36% | 59.55% | 109.32% | ||
| Operating Income | -71.49% | -4.91% | 33.37% | ||
| Income Before Tax | 15.47% | -11.74% | 38.48% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | 15.47% | -11.74% | 38.48% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 15.46% | -12.27% | 38.35% | ||
| EBIT | -71.49% | -4.91% | 33.37% | ||
| EBITDA | -67.31% | -1.51% | 36.79% | ||
| EPS Basic | 17.36% | -10.87% | 58.59% | ||
| Normalized Basic EPS | -58.97% | -10.34% | 58.75% | ||
| EPS Diluted | 17.36% | -10.87% | 58.59% | ||
| Normalized Diluted EPS | -58.97% | -10.34% | 58.75% | ||
| Average Basic Shares Outstanding | 2.97% | 1.16% | 48.73% | ||
| Average Diluted Shares Outstanding | 2.97% | 1.16% | 48.73% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||